Bioline Rx Income from Cont. Ops Quarterly
Bioline Rx Income from Cont. Ops Quarterly Chart
Bioline Rx Historical Income from Cont. Ops Quarterly DataPro Data Export
There is no data for the selected date range.
About Income from Continuing Operations
Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.
For instance, if MSFT had five billion in Income, and 2 billion in an exceptional item charge, its income would be a reported 3 billion. Because the exceptional charge is unlikely to be repeated in the next quarter, some investors prefer to see what MSFT's income was BEFORE charges.
View Income from Cont. Ops Quarterly for BLRX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
BLRX Income from Cont. Ops Quarterly Benchmarks
|Array BioPharma||Go Pro|
|Oramed Pharmaceuticals||Go Pro|
BLRX Income from Cont. Ops Quarterly Rankings
4442 of 8009
406 of 687 in Healthcare
102 of 248 in Biotechnology
BLRX Income from Cont. Ops Quarterly Range, Past 5 Years
|Minimum||Go Pro||Jun 2010|
|Maximum||Go Pro||Sep 2010|
Street Insider May 17
Business Wire May 7
Business Wire Apr 30
Street Insider Apr 29